Elżbieta Nowara

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 227 citations

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Ahmad Awada, Igor Bondarenko, J. Bonneterre et al. · Annals of Oncology · 2014 · 133 citations · Full text

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type <i>KRAS</i> Metastatic Colorectal Cancer

Eric Van Cutsem, Cathy Eng, Elżbieta Nowara et al. · Clinical Cancer Research · 2014 · 107 citations · Full text

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

G. Deplanque, Martin Demarchi, Mohamed Hebbar et al. · Annals of Oncology · 2015 · 92 citations · Full text

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Allen Lee Cohn, Josep Tabernero, Joan Maurel et al. · Annals of Oncology · 2013 · 88 citations · Full text

Second-line Treatment, Placebo-controlled Phase 2, Oncology +9